Interventional Radiology: Zapping Uterine Fibroids With Heat From High-energy Sound Waves

MR-guided Focused Ultrasound Offers Women Another Minimally Invasive Treatment
to Remove Uterine Fibroids-Avoiding Surgical Myomectomy and Hysterectomy

TAMPA, Fla., March 15 /PRNewswire-USNewswire/ -- There's a new
interventional radiology tool showing promise in the treatment of uterine
fibroids: magnetic resonance-guided focused ultrasound (MRgFUS), a minimally
invasive treatment that uses high-energy ultrasound waves to generate heat at
a specific point to destroy uterine fibroid tissue and relieve symptoms. A
study of more than 100 patients shows that women can get lasting relief from
uterine fibroid-related symptoms with MRgFUS-thus avoiding myomectomy, the
surgical removal of uterine fibroids, or hysterectomy, major abdominal surgery
to remove the uterus, say researchers at the Society of Interventional
Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100127/SIRLOGO)

"Our 119-patient study shows that magnetic resonance-guided focused ultrasound
is highly effective and can provide lasting relief from uterine
fibroid-related symptoms," said Gina Hesley, M.D., Mayo Clinic in Rochester,
Minn. In the 12 months following MRgFUS treatment, 97 percent of the women
reported improvement of their symptoms, with 90 percent of women rating their
improvement as either considerable or excellent. "MRgFUS is newer than another
interventional radiology fibroid treatment-uterine fibroid embolization or
UFE-a widely available treatment that blocks blood flow to fibroid tumors. Our
results with effectiveness of MRgFUS technology are promising and comparable
with that of UFE, but its longer-term effectiveness needs continued study,"
said Hesley. "Today, women have interventional radiology options that do not
involve the use of a scalpel incision. Women should ask for a consult with an
interventional radiologist who can determine from MR imaging whether they are
candidates for either procedure," she added.

Uterine fibroids are very common noncancerous (benign) growths that develop in
the muscular wall of the uterus. They can cause prolonged, heavy menstrual
bleeding that can be severe enough to cause anemia or require transfusion,
disabling pelvic pain and pressure, urinary frequency, pain during
intercourse, miscarriage, interference with fertility and an abnormally large
uterus resembling pregnancy. Twenty to 40 percent of women age 35 and older
have uterine fibroids of a significant size. African-American women are at a
higher risk for fibroids: as many as 50 percent have fibroids of a significant
size.

MRgFUS is performed as an outpatient procedure; it uses high-intensity focused
ultrasound waves-that can pass through skin, muscle, fat and other soft
tissues-to destroy (ablate) fibroid tissue. During treatment, the physician
uses magnetic resonance imaging (MRI) to see inside the body to deliver the
treatment directly to the fibroid. MRI scans identify the tissue in the body
to treat and are used to plan each patient's procedure. MRI provides a
three-dimensional view of the targeted tissue, allowing for precise focusing
and delivery of the ultrasound energy. MRI also enables the physician to
monitor tissue temperature in real-time to ensure adequate-but safe-heating of
the target. Immediate imaging of the treated area following MRgFUS helps the
physician determine the success of the treatment. The procedure was approved
by the Food and Drug Administration for treating uterine fibroids in October
2004; however, it is still considered new, is not widely available and not all
insurance carriers cover it.

In the nearly three-year study, 119 women completed MRgFUS treatment at the
Mayo Clinic and were followed for 12 months using phone interviews to assess
fibroid-related symptoms and symptomatic relief. Of the 89 patients who were
available for phone interviews at 12 months, 69 indicated they received from
the following relief from symptoms: excellent (74 percent), considerable (16
percent), moderate (9 percent) and insignificant (1 percent). The rate of
additional treatments needed post-MRgFUS was 8 percent, which is within values
reported for myomectomy and uterine fibroid embolization, said Hesley.

The Mayo researchers will continue to study two-year and three-year results of
symptom relief. They will also compare their current results with those
reported for myomectomy and uterine artery embolization and investigate the
efficacy of MRgFUS in treating other uterine conditions, such as adenomyosis,
a condition in which tissue that normally lines the uterus also grows within
the muscular walls of the uterus, said Hesley.

More information about the Society of Interventional Radiology, interventional
radiologists and treatments for uterine fibroids-both MR-guided focused
ultrasound and UFE-can be found online at www.SIRweb.org.

Abstract 56: "Magnetic Resonance-guided Focused Ultrasound of Uterine
Fibroids: Patient Follow-up 12 Months After Treatment," G.K. Hesley, K.R.
Gorny, D.A. Woodrum, D.L. Brown, K.R. Brandt, T.L. Henrichsen, J.P.
Felmlee, N.J. Hangiandreou, B.S. Gostout, E.A. Stewart, all at the Mayo
Clinic, Rochester, Minn., SIR 35th Annual Scientific Meeting March 13-18,
2010, Tampa, Fla.. This abstract can be found at www.SIRmeeting.org.

About the Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally
invasive, targeted treatments. They offer the most in-depth knowledge of the
least invasive treatments available coupled with diagnostic and clinical
experience across all specialties. They use X-ray, MRI and other imaging to
advance a catheter in the body, such as in an artery, to treat at the source
of the disease internally. As the inventors of angioplasty and the
catheter-delivered stent, which were first used in the legs to treat
peripheral arterial disease, interventional radiologists pioneered minimally
invasive modern medicine. Today, interventional oncology is a growing
specialty area of interventional radiology. Interventional radiologists can
deliver treatments for cancer directly to the tumor without significant side
effects or damage to nearby normal tissue.

Many conditions that once required surgery can be treated less invasively by
interventional radiologists. Interventional radiology treatments offer less
risk, less pain and less recovery time compared to open surgery. Visit
www.SIRweb.org.

The Society of Interventional Radiology is holding its 35th Annual Scientific
Meeting March 13-18 in Tampa, Fla. The theme of the meeting is "IR
Innovation," celebrating the remarkable inventiveness of SIR members and
highlighting the contributions made to both creating the field of
interventional radiology and to improving patient care.

SOURCE Society of Interventional Radiology

Maryann Verrillo, +1-703-460-5572; Diane Shnitzler, +1-703-460-5582; March
11-12: Lisa Tadje, +1-212-453-2137; or Don Murphy, +1-212-453-2462; or Neil
Hochman, +1-212-453-2067; March 13-18: Tampa Press Room, +1-813-276-6905,
+1-813-276-6906, or +1-813-276-6912, comm@SIRweb.org